For cancer patients, every day of treatment is critical. But the best care possible is not always reaching patients quickly . Despite Health Canada approving a drug treating an aggressive blood cancer, a complex web of organizations, insurance plans and negotiations over drug pricing means it’s still not available in Canada. Globe reporters Kelly Grant , who covers health, and Chris Hannay , who covers the business of health care, tell us what is holding up life-changing drugs and why Canadian patients are the ones left with the consequences. Questions? Comments? Ideas? Email us at
[email protected] Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
